assurance maladie maternité – Remboursement du test western blot de la maladie de Lyme

This written question asks about the reimbursement of the Western blot test for Lyme disease under the French health insurance system. It seeks clarification on current policies and potential improvements to ensure adequate coverage for diagnostic testing. The question affects individuals seeking diagnosis for Lyme disease and healthcare providers. It could lead to changes in reimbursement policies, impacting access to timely and accurate testing for patients.